Senior insider sale
Chief Medical Officer at ICOSAVAX, INC. — senior position signals high conviction
$183.7K
11.88K shares
What this filing means
KANESA-THASAN NIRANJAN plans to sell 11.88K shares of ICOSAVAX, INC. valued at approximately $183.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/20/2023ACC: 0000950170-23-072027
Officer· Chief Medical Officer
Since Jul 2021
11.88K
Shares to sell
$183.7K
Approx. market value
35.36K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares acquired upon vesting of restricted stock units
Services Rendered
12/20/2023
35.36KTotal acquired35.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2023 | Shares acquired upon vesting of restricted stock units Services Rendered | 35.36K | — |
| Total | 35.36K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.88K
Market value
$183.7K
12/20/2023
Total
Units
11.88K
Value
$183.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/20/2023 | 11.88K | $183.7K | NASDAQ | Planned |
| Total | 11.88K | $183.7K | ||